1 / 4

US Myocardial Infarction Market Size, Share & forecast to 2026

The US is expected to make a major contribution to the MI treatment market due to the rise in the adoption of hybrid operating rooms and innovative treatment technology. Hospitals and clinics in the US are well equipped with the latest treatment devices which are essential to perform critical MI surgeries. Cleveland Clinic, Mayo Clinic, New York-Presbyterian University Hospital of Columbia and Cornell are some of the key hospitals contributing to the growth of the MI treatment market. In 2019, the average cardiology procedures which include bypass surgery ranges from $56,000 to $200,000 in the US. The cost of heart valve replacement surgery costs around $80,000- $200,000. Additionally, various physical therapies followed by surgery may cost around $50-$350 per session, according to the Center for Medicare & Medicaid Services.

larebomrglobal
Download Presentation

US Myocardial Infarction Market Size, Share & forecast to 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research US Myocardial Infarction Market:Industry Growth, Size, Share and Forecast 2019-2025 Request a Free Sample of Report on https://www.omrglobal.com/request-sample/canada-silent-heart-attack-market ------------------------------------------------------------------------------------ Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780304040 US Myocardial Infarction Market @

  2. Canada silent heart attack market is estimated to grow modestly at a CAGR of around 8.4% during the forecast period. Canada has a considerable market of silent heart attack treatment due to the huge investment of government in healthcare facilities and the adoption of innovative technologies in the healthcare domain. Cardiac procedures and other heart surgeries are comparatively economical in Canada compared to the US. The cost of CABG and other cardiology surgeries in Canada is around 40-50% lower than the US. Moreover, Canada has more favorable government policies and regulations as compared to the US which enable Canadian citizens to reduce the cost of surgeries and hospital stay in the country Every Canadian has a health card issued by Provincial Ministry of Health to avail the benefits of healthcare program. It is estimated that around 70% of Canadian healthcare cost is paid or reimbursed by the Canadian Government. A full Report of US Myocardial Infarction Market at https://www.omrglobal.com/industry-reports/canada- silent-heart-attack-market Canada silent heart attack market is segmented into diagnosis, treatment, and end-user. Based on the diagnosis, the market is segmented into an electrocardiography (ECG), chest x-ray, computed tomography (CT Scan), echocardiography, and others (blood test). Based on treatment, the market is segmented into medication and surgery. Based on end-user, the market is segmented into hospitals & clinics and ambulatory surgical centers (ASCs). Due to the severe pain associated with silent heart attack, medications are primarily required to relieve pain as well as to reduce blood clotting and relax heart muscle. The drugs enable to improve the heart functioning, widen, or dilate blood vessels, minimize pain, and protect against any life-threatening heart rhythms. Request a Free Sample of Report on US Myocardial https://www.omrglobal.com/request-sample/canada-silent-heart-attack-market US Myocardial Infarction Market Segmentation By Type Non-ST-elevation myocardial infarction (NSTEMI) ST-elevation myocardial infarction (STEMI) Silent Heart Attacks By Device Left Ventricular Assist Device (LVAD) Pacemaker Catheters Implantable Cardioverter-Defibrillator (ICD) Others (Stent Graft) By Diagnosis Electrocardiography (ECG) Chest X-Ray Computed Tomography (CT Scan) Infarction Market @

  3. Echocardiography Others (Blood Test) By Treatment Medication Surgery By End-User Hospital & Clinics Ambulatory Surgical Centers Research Institutes Regional Analysis China Japan India Rest of Asia-Pacific Company Profiles Abbott Laboratories Inc. AstraZeneca PLC Bayer AG Boston Scientific Corp. Bristol-Myers Squibb Co. CSL Ltd. Eli Lilly and Co. GlaxoSmithKline Plc Johnson & Johnson Services, Inc. Medtronic PLC Merck KGaA Mesoblast Ltd. Mylan N.V. Novartis AG Pfizer Inc. Siemens AG For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/canada-silent-heart-attack-market

  4. About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

More Related